Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M377Revenue (TTM) $M244Net Margin (%)26.0Altman Z-Score2.3
Enterprise Value $M424EPS (TTM) $0.4Operating Margin %53.0Piotroski F-Score4
P/E(ttm)6.0Beneish M-Score1.4Pre-tax Margin (%)44.8Higher ROA y-yN
Price/Book0.510-y EBITDA Growth Rate %2.1Quick Ratio3.0Cash flow > EarningsY
Price/Sales1.65-y EBITDA Growth Rate %-8.2Current Ratio3.1Lower Leverage y-yY
Price/Free Cash Flow3.8y-y EBITDA Growth Rate %-75.0ROA % (ttm)5.7Higher Current Ratio y-yN
Dividend Yield %2.2PEG--ROE % (ttm)8.7Less Shares Outstanding y-yN
Payout Ratio %26.0Shares Outstanding M166ROIC % (ttm)10.0Gross Margin Increase y-yN

Gurus Latest Trades with PDLI

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

PDLI is held by these investors:



PDLI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GARCIA PETER SVice President, CFO 2017-03-24Buy25,000$1.9816.67view
GARCIA PETER SVice President, CFO 2016-08-09Buy10,000$3-23view
GARCIA PETER SVice President, CFO 2015-12-15Buy15,000$3.5-34view
Pietzke SteffenController and CAO 2015-12-07Buy20,590$3.64-36.54view
GARCIA PETER SVice President, CFO 2015-08-14Buy20,000$5.83-60.38view
SELICK HAROLD EDirector 2014-11-26Buy6,000$8.08-71.41view
Lindell Jody SDirector 2011-03-15Buy374$5.33-56.66view
LARSON CHRISTINE RVice President and CFO 2010-05-14Buy5,000$5.71-59.54view
LARSON CHRISTINE RVice President and CFO 2010-04-30Buy10,000$6.18-62.62view
KLEIN JOSEPH IIIDirector 2009-11-04Sell24,000$8.33-72.27view

Press Releases about PDLI :

Quarterly/Annual Reports about PDLI:

News about PDLI:

Articles On GuruFocus.com
PDL BioPharma to Announce First Quarter 2017 Financial Results on May 3, 2017 Apr 26 2017 
PDL BioPharma Announces Settlement of Keytruda Patent Infringement Lawsuit with Merck Apr 24 2017 
PDL BioPharma to Hold Annual Meeting of Stockholders on June 9, 2017 Apr 06 2017 
8 High-Yield Stocks With Falling Prices Feb 21 2017 
Medical Companies Offer Good Value Opportunities Sep 16 2016 
Undervalued Companies With Growing EPS Apr 04 2016 
Cash is Flowing Nicely for These Five Stocks Aug 19 2015 
Context Capital Management's Top Buys in Q2 2015 Jul 15 2015 
Weekly 3-Year Low Highlights: APOL, PDLI, TC, ALLT, ELRC May 17 2015 
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against PDL BioPharma, Oct 17 2014 

More From Other Websites
PDL BioPharma, Inc. – Value Analysis (NASDAQ:PDLI) : April 26, 2017 Apr 26 2017
PDL BioPharma to Announce First Quarter 2017 Financial Results on May 3, 2017 Apr 26 2017
PDL BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : PDLI-US : April 25,... Apr 25 2017
ETFs with exposure to PDL BioPharma, Inc. : April 24, 2017 Apr 24 2017
Sarepta Pops on Bullish Sentiment Around Duchenne Therapy, PDL Up on Merck Deal: Biotech Movers Apr 24 2017
PDL BioPharma to be paid $19.5 million by Merck to settle Keytruda patent suit Apr 24 2017
PDL BioPharma Announces Settlement of Keytruda Patent Infringement Lawsuit with Merck Apr 24 2017
PDL BioPharma to Hold Annual Meeting of Stockholders on June 9, 2017 Apr 06 2017
PDL BioPharma (PDLI) Up 5.9% Since Earnings Report: Can It Continue? Apr 03 2017
Today's Research Reports on Stocks to Watch: Celldex Therapeutics and PDL BioPharma Mar 31 2017
ETFs with exposure to PDL BioPharma, Inc. : March 27, 2017 Mar 27 2017
PDL BioPharma, Inc. :PDLI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017 Mar 17 2017
PDL BioPharma to Present at the Oppenheimer 27th Annual Healthcare Conference Mar 14 2017
PDL BioPharma, Inc. :PDLI-US: Earnings Analysis: 2016 By the Numbers : March 10, 2017 Mar 10 2017
Why Tenet Healthcare, Scientific Games, and PDL BioPharma Jumped Today Mar 03 2017
PDL BioPharma to Present at Two Upcoming Investor Conferences Mar 02 2017
Edited Transcript of PDLI earnings conference call or presentation 1-Mar-17 9:30pm GMT Mar 01 2017
PDL BioPharma reports 4Q loss Mar 01 2017
PDL BioPharma Announces Fourth Quarter and Year End 2016 Financial Results Mar 01 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)